Central Trust Company’s Innophos Holdings, Inc. IPHS Stock Holding History

Central Trust Company’s Portfolio IPHS Stock Details IPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$32K	–	1247
2019 Q4	$32K	Hold	1,000	–	–	﹤0.01%	754
2019 Q3	$32K	Hold	1,000	–	–	﹤0.01%	720
2019 Q2	$27K	Hold	1,000	–	–	﹤0.01%	755
2019 Q1	$30K	Hold	1,000	–	–	﹤0.01%	713
2018 Q4	$25K	Hold	1,000	–	–	﹤0.01%	745
2018 Q3	$44K	Sell	1,000 -4,803	-83%	-$220K	﹤0.01%	707
2018 Q2	$277K	Hold	5,803	–	–	0.02%	406
2018 Q1	$233K	Hold	5,803	–	–	0.01%	437
2017 Q4	$271K	Hold	5,803	–	–	0.02%	429
2017 Q3	$285K	Hold	5,803	–	–	0.02%	402
2017 Q2	$255K	Buy	5,803 +1,000	+21%	+$44.9K	0.02%	405
2017 Q1	$259K	Hold	4,803	–	–	0.02%	405
2016 Q4	$251K	Buy	+4,803	New	+$233K	0.02%	407

Other funds holding IPHS

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Central Trust Company's IPHS Position: Q1 2020 in Review

Central Trust Company sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 1,000 shares — an estimated $32K sold.

Central Trust Company first reported a position in IPHS in Q4 2016 and held it in 13 quarters. The position peaked at $285K in Q3 2017. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

Central Trust Company reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
Central Trust Company sold 1,000 Innophos Holdings, Inc. shares in Q1 2020, an estimated $32K.
Central Trust Company first reported a position in Innophos Holdings, Inc. in Q4 2016 and held it in 13 quarters.
Central Trust Company's Innophos Holdings, Inc. position peaked at $285K in Q3 2017.
2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Central Trust Company's 13F filing for Q1 2020, filed 17 Apr 2020.